| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 09/10/2008 | CN100417653C Preparation method of thienotetrahydropyridinacetic acid and salt thereof |
| 09/09/2008 | US7423058 Inhibitors of hepatitis C virus NS3 protease |
| 09/09/2008 | US7423056 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | CA2359357C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 09/04/2008 | WO2008106194A1 Carboxylic acid-modified edot for bioconjugation |
| 09/04/2008 | WO2008106019A2 Fused thiophenes, methods for making fused thiophenes, and uses thereof |
| 09/04/2008 | WO2008104175A2 Novel phosphodiesterase inhibitors |
| 09/04/2008 | US20080214839 organic semiconductor, hole conducting, or light-emitting materials; can be spin-coated at room temperature, are stable, and has superior electrical conductivity |
| 09/04/2008 | US20080214821 Methyl (S)-(+)- alpha -(2-chlorophenyl)-6,7-dihydrothieno[3,2-a]pyridine-5(4H)-acetate; high yield; stroke, thrombosis and embolism |
| 09/04/2008 | US20080214643 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/04/2008 | US20080214579 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/04/2008 | US20080214576 Topoisomerase Inhibitors and Prodrugs |
| 09/04/2008 | CA2676933A1 Novel phosphodiesterase inhibitors |
| 09/03/2008 | EP1964842A1 5H-THIENO [3,4-c]PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR |
| 09/03/2008 | EP1963338A1 New compounds |
| 09/03/2008 | EP1963337A1 New compounds |
| 09/03/2008 | EP1963336A1 New compounds |
| 09/03/2008 | EP1963335A2 Process for the preparation of olanzapine |
| 09/03/2008 | EP1963275A2 P2x7 receptor antagonists and uses thereof |
| 09/03/2008 | EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 09/03/2008 | CN101258156A Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 09/03/2008 | CN101257970A 硫代内酯的制造 Thiolactone manufacturing |
| 09/03/2008 | CN101255169A Prasugrel salt and preparation method thereof |
| 09/03/2008 | CN100415739C Photochromic diarylethene-containing coordination compounds and the production thereof |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/02/2008 | US7420065 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 09/02/2008 | US7419985 reuptake of norephinephrine, dopamine, and serotonin inhibitor; furo-, pyrrolo-, and thienyl-tetrahydroisoquinolines, e.g. 2 methyl 4 phenyl 1,2,3,4,8,9 hexahydro furo[2,3 h]isoquinoline; antidepressant, anxiolytic agent; neurological and psychological disorders |
| 09/02/2008 | US7419978 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors |
| 09/02/2008 | CA2294351C Compounds useful for inhibition of farnesyl protein transferase |
| 08/28/2008 | WO2008103357A1 Fungicidal tricyclic 1,2,4-triazoles |
| 08/28/2008 | WO2008103351A2 Heterocyclic aspartyl protease inhibitors |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008101660A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | WO2008101659A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | WO2008073785A3 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207611 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders |
| 08/28/2008 | US20080207609 Anticancer agents; kinase inhibitor; immunotherapy; viricides; antiinflammatory agents |
| 08/28/2008 | US20080206597 Stability; efficiency; hole injection or hole transporting material |
| 08/28/2008 | CA2679173A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | CA2679166A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | CA2678958A1 Heterocyclic aspartyl protease inhibitors |
| 08/27/2008 | EP1960405A2 Method of modulating stress-activated protein kinase system |
| 08/27/2008 | EP1960382A1 Heterocyclic compounds as tyrosine kinase modulators |
| 08/27/2008 | EP1960372A1 Kinase inhibitors and their uses |
| 08/27/2008 | EP1626974B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 08/27/2008 | EP1349858B1 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 08/27/2008 | CN101253179A Novel resinate complex of S-clopidogrel and production method thereof |
| 08/27/2008 | CN101253147A Organic compounds |
| 08/27/2008 | CN101250193A Method for preparing 2-methoxy-5-(alpha-cyclopropyl carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothiophene [3,2-c] pyridine |
| 08/27/2008 | CN101250192A Method for preparing 5-(alpha-cyclopropyl carbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothiophene [3,2-c] pyridine |
| 08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
| 08/26/2008 | CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/21/2008 | WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases |
| 08/21/2008 | WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008099020A1 1,1-dioxo-1-thia-5,10-diazadibenzocycloheptenes useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008080134A3 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors |
| 08/21/2008 | WO2008075148A3 Tricyclic inhibitors of carbonic anhydrase |
| 08/21/2008 | US20080200674 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents;Alzheimer's disease; anticancer agents |
| 08/21/2008 | US20080200497 inhibitors of the hepatitis C virus NS3 protease; azalactone intermediate reacted with cycloalkylsulfonamide and decylization; urea or carbamate-terminated alkylglycine. hydroxyproline, cyclopropylglycine tripeptide |
| 08/21/2008 | US20080200475 platelet dependent thrombosis; P2Y12 receptor antagonists; Ethyl N-[({4-[4-(1,1'-biphenyl-4-ylcarbonyl)piperazin-1-yl]-6-ethylthieno[- 2,3-d]pyrimidin-2-yl}amino)carbonyl]glycinate |
| 08/21/2008 | US20080200469 Phthalazinone derivatives |
| 08/20/2008 | EP1957498A2 Inhibitors of vegf receptor and hgf receptor signaling |
| 08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/20/2008 | EP1569935B1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors |
| 08/20/2008 | CN101248080A Inhibitors of VEGF receptor and HGF receptor signaling |
| 08/20/2008 | CN101248059A Substituted amide derivatives as protein kinase inhibitors |
| 08/20/2008 | CN101245073A Medicine midbody and preparation method thereof |
| 08/20/2008 | CN101245072A Midbody for producing prasugrel and producing method thereof |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/14/2008 | WO2008096791A1 Acylguanidine derivative |
| 08/14/2008 | WO2008096760A1 NOVEL HEXATRIENE-β-CARBONYL COMPOUND |
| 08/14/2008 | WO2008019292A3 Compositions and methods for potentiating antibiotic activity |
| 08/14/2008 | WO2007072158A8 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
| 08/14/2008 | US20080193413 Anti-Infective Agents |
| 08/14/2008 | CA2677995A1 Acylguanidine derivative |
| 08/14/2008 | CA2677263A1 Compounds and compositions as modulators of gpr119 activity |
| 08/14/2008 | CA2676422A1 Oxabicycloheptane and oxabicycloheptene phosphatase inhibitors, their preparation and use |
| 08/13/2008 | EP1956009A1 Aromatic compound |
| 08/13/2008 | EP1620401A4 Phenyl substituted cyclic derivatives |
| 08/13/2008 | EP1020445B1 Fused pyridine derivatives |
| 08/13/2008 | CN101239062A Use of 5-HT5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 08/12/2008 | US7411074 Cyclizing an N-carboxymethyl-N-alkanoyl-3-formyl-2-thiophenylamine and optionally amidating the product |
| 08/12/2008 | US7410982 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 08/12/2008 | CA2304568C Olanzapine pamoate formulations |
| 08/07/2008 | WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| 08/07/2008 | WO2008094476A1 Substituted pyrano [2, 3 - b] pyridine derivatives as cannabinoid -1 receptor modulators |
| 08/07/2008 | WO2008094473A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 08/07/2008 | WO2008093881A1 Method for synthesis of nitroxyl radical |
| 08/07/2008 | WO2008093357A2 Process for preparation of crystalline clopidogrel hydrogen sulphate form i |
| 08/07/2008 | WO2008092862A1 Bicyclic derivatives as ep4 agonists |
| 08/07/2008 | WO2008092860A1 Bicyclic derivatives as ep4 agonists |
| 08/07/2008 | WO2008064018A8 Thienopyrimidinones for treatment of inflammatory disorders and cancers |